Competitive Intelligence: Who are the Key Manufacturers Shaping the Future?
The competitive landscape for Duchenne Muscular Dystrophy is a mix of established pharmaceutical giants and nimble, high-tech biotech firms. The race to dominate this space is intense, with companies competing on multiple fronts: gene therapy, exon skipping, and small molecule anti-inflammatories. Being "first-to-market" is a huge advantage, but "best-in-class" is the ultimate goal. The...
0 Commentaires 0 Parts 35 Vue 0 Aperçu